Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

701 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy.
Giossi R, Consonni A, Torri Clerici V, Zito A, Rigoni E, Antozzi C, Brambilla L, Crisafulli SG, Bellino A, Frangiamore R, Bonanno S, Vanoli F, Ciusani E, Corsini E, Andreetta F, Baggi F, Tramacere I, Mantegazza R, Conte A, Bergamaschi R, Confalonieri P. Giossi R, et al. Among authors: bergamaschi r. Mult Scler Relat Disord. 2022 Feb;58:103415. doi: 10.1016/j.msard.2021.103415. Epub 2021 Nov 22. Mult Scler Relat Disord. 2022. PMID: 35216790 Free PMC article.
Immunomodulatory therapies delay disease progression in multiple sclerosis.
Bergamaschi R, Quaglini S, Tavazzi E, Amato MP, Paolicelli D, Zipoli V, Romani A, Tortorella C, Portaccio E, D'Onghia M, Garberi F, Bargiggia V, Trojano M. Bergamaschi R, et al. Mult Scler. 2016 Nov;22(13):1732-1740. doi: 10.1177/1352458512445941. Epub 2012 May 31. Mult Scler. 2016. PMID: 22653657
The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.
D'Amico E, Leone C, Graziano G, Amato MP, Bergamaschi R, Cavalla P, Coniglio G, Di Battista G, Ferrò MT, Granella F, Granieri E, Lugaresi A, Lus G, Millefiorini E, Pozzilli C, Tedeschi G, Zappia M, Comi G, Trojano M, Lepore V, Patti F. D'Amico E, et al. Among authors: bergamaschi r. PLoS One. 2016 Jun 27;11(6):e0157721. doi: 10.1371/journal.pone.0157721. eCollection 2016. PLoS One. 2016. PMID: 27348606 Free PMC article. Clinical Trial.
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study.
Baroncini D, Zaffaroni M, Moiola L, Lorefice L, Fenu G, Iaffaldano P, Simone M, Fanelli F, Patti F, D'Amico E, Capobianco M, Bertolotto A, Gallo P, Margoni M, Miante S, Milani N, Amato MP, Righini I, Bellantonio P, Scandellari C, Costantino G, Scarpini E, Bergamaschi R, Mallucci G, Comi G, Ghezzi A. Baroncini D, et al. Among authors: bergamaschi r. Mult Scler. 2019 Mar;25(3):399-407. doi: 10.1177/1352458518754364. Epub 2018 Jan 24. Mult Scler. 2019. PMID: 29363396
Risk of secondary progressive multiple sclerosis: A longitudinal study.
Fambiatos A, Jokubaitis V, Horakova D, Kubala Havrdova E, Trojano M, Prat A, Girard M, Duquette P, Lugaresi A, Izquierdo G, Grand'Maison F, Grammond P, Sola P, Ferraro D, Alroughani R, Terzi M, Hupperts R, Boz C, Lechner-Scott J, Pucci E, Bergamaschi R, Van Pesch V, Ozakbas S, Granella F, Turkoglu R, Iuliano G, Spitaleri D, McCombe P, Solaro C, Slee M, Ampapa R, Soysal A, Petersen T, Sanchez-Menoyo JL, Verheul F, Prevost J, Sidhom Y, Van Wijmeersch B, Vucic S, Cristiano E, Saladino ML, Deri N, Barnett M, Olascoaga J, Moore F, Skibina O, Gray O, Fragoso Y, Yamout B, Shaw C, Singhal B, Shuey N, Hodgkinson S, Altintas A, Al-Harbi T, Csepany T, Taylor B, Hughes J, Jun JK, van der Walt A, Spelman T, Butzkueven H, Kalincik T. Fambiatos A, et al. Among authors: bergamaschi r. Mult Scler. 2020 Jan;26(1):79-90. doi: 10.1177/1352458519868990. Epub 2019 Aug 9. Mult Scler. 2020. PMID: 31397221
A method to compare prospective and historical cohorts to evaluate drug effects. Application to the analysis of early treatment effectiveness of intramuscular interferon-β1a in multiple sclerosis patients.
Mallucci G, Patti F, Brescia Morra V, Buccafusca M, Moiola L, Amato MP, Ferraro E, Trojano M, Zaffaroni M, Mirabella M, Moscato G, Plewnia K, Zipoli V, Puma E, Bergamaschi R; BREMSO-group. Mallucci G, et al. Among authors: bergamaschi r. Mult Scler Relat Disord. 2020 May;40:101952. doi: 10.1016/j.msard.2020.101952. Epub 2020 Jan 21. Mult Scler Relat Disord. 2020. PMID: 32007656
Unraveling a new player in multiple sclerosis pathogenesis: The RNA-binding protein HuR.
Pistono C, Monti MC, Marchesi N, Boiocchi C, Campagnoli LIM, Morlotti D, Cuccia M, Govoni S, Montomoli C, Mallucci G, Bergamaschi R, Pascale A. Pistono C, et al. Among authors: bergamaschi r. Mult Scler Relat Disord. 2020 Jun;41:102048. doi: 10.1016/j.msard.2020.102048. Epub 2020 Mar 8. Mult Scler Relat Disord. 2020. PMID: 32200342
701 results